Abstract
Peripheral T-cell lymphomas (PTCL) constitute a heterogeneous group of rare malignancies, derived from the monoclonal proliferation of post-thymic and activated T-cells and natural-killer (NK) lymphocytes. PTCL encompasses heterogeneous disorders, with distinct clinical, histopathological, immunophenotypic and molecular-genetic characteristics. To date, 29 specific subtypes of PTCL have b…